Keith Syson Chan
Affiliations: | 2004-2009 | Stem Cell & Regenerative Medicine Center | Stanford University, Palo Alto, CA |
2016- | Baylor College of Medicine, Houston, TX | ||
2019- | Cedars-Sinai Medical Center, Los Angeles, CA, United States |
Area:
PathologyWebsite:
https://alliedacademies.com/profile/Keith%20Syson%20ChanGoogle:
"Keith Syson Chan"Mean distance: (not calculated yet)
Parents
Sign in to add mentorJohn DiGiovanni | grad student | 2004 | The University of Texas Graduate School of Biomedical Sciences at Houston (Chemistry Tree) | |
(Significance of signal transducer and activator of transcription 3 during multistage mouse skin carcinogenesis.) | ||||
Irving L. Weissman | post-doc | 2004-2009 | Stanford (FlyTree) |
Children
Sign in to add traineeErica Lay | research assistant | 2010-2012 | Baylor College of Medicine |
Zoe Tramel | research assistant | 2015-2017 | Baylor College of Medicine |
Kazukuni Hayashi | grad student | Cedars-Sinai Medical Center | |
Antonina Kurtova | grad student | 2010-2015 | Baylor College of Medicine |
Philip Levy Ho | post-doc | Kelsey-Seybold Clinic/Baylor College of Medicine | |
Fotis Nikolo | post-doc | Cedars-Sinai Medical Center | |
Yu Cheng Lee | post-doc | 2015-2019 | Baylor College of Medicine |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Heiser CN, Simmons AJ, Revetta F, et al. (2023) Molecular cartography uncovers evolutionary and microenvironmental dynamics in sporadic colorectal tumors. Cell. 186: 5620-5637.e16 |
Riveros C, Ranganathan S, Haque W, et al. (2023) Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada |
Piras R, Ko EY, Barrett C, et al. (2022) circCsnk1g3- and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment. Nature Communications. 13: 7243 |
You S, Kim M, Hoi XP, et al. (2022) Discoidin domain receptor-driven gene signatures as markers of patient response to anti-PD-L1 immune checkpoint therapy. Journal of the National Cancer Institute |
Lee YC, Lam HM, Rosser C, et al. (2022) The dynamic roles of the bladder tumour microenvironment. Nature Reviews. Urology |
You S, Kim M, Widen S, et al. (2022) Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients. Urologic Oncology |
Nikolos F, Hayashi K, Hoi XP, et al. (2022) Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors. Nature Communications. 13: 1487 |
Tyner JW, Haderk F, Kumaraswamy A, et al. (2022) Understanding Drug Sensitivity and Tackling Resistance in Cancer. Cancer Research |
Pollan SG, Teng PC, Jan YJ, et al. (2021) Loss of CDCP1 triggers FAK activation in detached prostate cancer cells. American Journal of Clinical and Experimental Urology. 9: 350-366 |
Gouin KH, Ing N, Plummer JT, et al. (2021) An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer. Nature Communications. 12: 4906 |